{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:02:32Z","timestamp":1792854152877,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) represents a growing global health challenge, often progressing silently until advanced stages. Persistent proteinuria plays a pivotal role in initiating the fibrotic niche\u2014a complex cellular microenvironment contributing to early kidney fibrosis and closely associated with kidney failure. Despite advancements in CKD management, proteinuria remains underrecognized as a critical surrogate endpoint for disease progression. Urine screening for proteinuria in asymptomatic pediatric populations has been contentious due to concerns about diagnostic reliability, cost-effectiveness, and clinical relevance. However, recent data from Japan present a contrasting perspective. With a well-established nationwide school-based urine screening program, Japan has demonstrated effective early detection and intervention strategies, particularly for conditions such as IgA nephropathy. A 2024 economic evaluation reported an incremental cost-effectiveness ratio well below Japan\u2019s pediatric willingness-to-pay threshold, affirming the program\u2019s economic and clinical viability. These findings underscore the potential of structured screening protocols\u2014especially in regions with underreported disease prevalence or limited healthcare access\u2014to prevent long-term kidney impairment. Modifiable factors such as screening frequency, age of initiation, and integration of emerging biomarkers must be considered to optimize outcomes. This review highlights the need to revisit the role of proteinuria screening in pediatric nephrology, advocating for evidence-informed policy decisions that recognize its long-term value. Japan\u2019s model offers a robust framework for balancing cost, clinical impact, and public health priorities in global efforts to address CKD in its earliest stages.<\/jats:p>","DOI":"10.1007\/s00467-025-07098-1","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:51:47Z","timestamp":1765014707000},"page":"2337-2346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early detection of proteinuria to prevent kidney fibrosis and progression to kidney failure: lessons from the School Urine Screening Program in Japan"],"prefix":"10.1007","volume":"41","author":[{"given":"Rini","family":"Rossanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-8174","authenticated-orcid":false,"given":"Kazumoto","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"7098_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1053\/j.ajkd.2014.02.020","volume":"64","author":"LA Inker","year":"2014","unstructured":"Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) (2014) Early change in proteinuria as a surrogate endpoint for kidney disease progression: an individual patient meta-analysis. Am J Kidney Dis 64:74\u201385","journal-title":"Am J Kidney Dis"},{"key":"7098_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709\u2013733","journal-title":"Lancet"},{"key":"7098_CR3","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00467-006-0360-7","volume":"22","author":"RH Mak","year":"2007","unstructured":"Mak RH (2007) Chronic kidney disease in children: state of the art. Pediatr Nephrol 22:1687\u20131688","journal-title":"Pediatr Nephrol"},{"key":"7098_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0065-2423(09)49004-8","volume":"49","author":"MH Rosner","year":"2009","unstructured":"Rosner MH (2009) Urinary biomarkers for the detection of renal injury. Adv Clin Chem 49:73\u201397","journal-title":"Adv Clin Chem"},{"key":"7098_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.2215\/CJN.00600206","volume":"1","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Greene T, Levey AS (2006) Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol 1:874\u2013884","journal-title":"Clin J Am Soc Nephrol"},{"key":"7098_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7:182","journal-title":"Signal Transduct Target Ther"},{"key":"7098_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ki.2012.20","volume":"82","author":"I Grgic","year":"2012","unstructured":"Grgic I, Campanholle G, Bijol V, Wang C, Sabbisetti VS, Ichimura T, Humphreys BD, Bonventre JV (2012) Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82:172\u2013183","journal-title":"Kidney Int"},{"key":"7098_CR8","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1111\/j.1523-1755.2005.09406.x","volume":"94","author":"M Murakami","year":"2005","unstructured":"Murakami M, Hayakawa M, Yanagihara T, Hukunaga Y (2005) Proteinuria screening for children. Kidney Int Suppl 94:S23\u2013S27","journal-title":"Kidney Int Suppl"},{"key":"7098_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s00467-002-0848-8","volume":"17","author":"S Hattori","year":"2002","unstructured":"Hattori S, Yosioka K, Honda M, Ito H, Japanese Society for Pediatric Nephrology (2002) The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 17:456\u2013461","journal-title":"Pediatr Nephrol"},{"key":"7098_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10157-014-1077-8","volume":"19","author":"M Hattori","year":"2015","unstructured":"Hattori M, Sako M, Kaneko T, Ashida A, Matsunaga A, Igarashi T, Itami N, Ohta T, Gotoh Y, Satomura K, Honda M, Igarashi T (2015) End-stage renal disease in Japanese children: a nationwide survey during 2006\u20132011. Clin Exp Nephrol 19:933\u2013938","journal-title":"Clin Exp Nephrol"},{"key":"7098_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.08630910","volume":"6","author":"K Kamei","year":"2011","unstructured":"Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group (2011) Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin J Am Soc Nephrol 6:1301\u20131307","journal-title":"Clin J Am Soc Nephrol"},{"key":"7098_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2215\/CJN.01210308","volume":"4","author":"RJ Hogg","year":"2009","unstructured":"Hogg RJ (2009) Screening for CKD in children: a global controversy. Clin J Am Soc Nephrol 4:509\u2013515","journal-title":"Clin J Am Soc Nephrol"},{"key":"7098_CR13","unstructured":"The American Academy of Family Physicians Foundation (n.d.) Don\u2019t order routine screening urinalysis in healthy, asymptomatic pediatric patients as part of routine well-child care. Choosing Wisely Recommendations. https:\/\/www.aafp.org\/pubs\/afp\/collections\/choosing-wisely\/359.html. Accessed 1 Aug 2025"},{"key":"7098_CR14","first-page":"16","volume":"31","author":"W Primack","year":"2010","unstructured":"Primack W (2010) AAP does not recommend routine urinalysis for asymptomatic youths. AAP News 31:16","journal-title":"AAP News"},{"key":"7098_CR15","unstructured":"Haider MZ, Aslam A (2023) Proteinuria: In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, National Center for Biotechnology Information, National Library of Medicine, NIH. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564390\/.\u00a0Accessed 10 Oct 2025"},{"key":"7098_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1523-1755.2003.00840.x","volume":"63","author":"G D\u2019Amico","year":"2003","unstructured":"D\u2019Amico G, Bazzi C (2003) Pathophysiology of proteinuria. Kidney Int 63:809\u2013825","journal-title":"Kidney Int"},{"key":"7098_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.ackd.2011.03.002","volume":"18","author":"G Viswanathan","year":"2011","unstructured":"Viswanathan G, Upadhyay A (2011) Assessment of proteinuria. Adv Chronic Kidney Dis 18:243\u2013248","journal-title":"Adv Chronic Kidney Dis"},{"key":"7098_CR18","first-page":"14","volume-title":"Comprehensive Clinical Nephrology","author":"M Bailey","year":"2019","unstructured":"Bailey M, Shirley D, Unwin R (2019) Renal physiology. In: Feehally J, Floege J, Tonelli M, Johnson RJ (eds) Comprehensive Clinical Nephrology, 6th edn. Elsevier, Edinburgh, pp 14\u201328","edition":"6"},{"key":"7098_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000516911","volume":"46","author":"S Sharma","year":"2021","unstructured":"Sharma S, Smyth B (2021) From proteinuria to fibrosis: an update on pathophysiology and treatment options. Kidney Blood Press Res 46:411\u2013420","journal-title":"Kidney Blood Press Res"},{"key":"7098_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.kint.2016.03.026","volume":"90","author":"I Burlaka","year":"2016","unstructured":"Burlaka I, Nilsson LM, Scott L, Holtb\u00e4ck U, Ekl\u00f6f AC, Fogo AB, Brismar H, Aperia A (2016) Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease. Kidney Int 90:135\u2013148","journal-title":"Kidney Int"},{"key":"7098_CR21","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1046\/j.1523-1755.63.s84.13.x","volume":"84","author":"V Wohlfarth","year":"2003","unstructured":"Wohlfarth V, Drumm K, Mildenberger S, Freudinger R, Gekle M (2003) Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells. Kidney Int Suppl 84:S103\u2013S109","journal-title":"Kidney Int Suppl"},{"key":"7098_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L (2023) Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther 8:129","journal-title":"Signal Transduct Target Ther"},{"key":"7098_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.kint.2016.09.037","volume":"91","author":"JJ Carrero","year":"2017","unstructured":"Carrero JJ, Grams ME, Sang Y, \u00c4rnl\u00f6v J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J (2017) Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int 91:244\u2013251","journal-title":"Kidney Int"},{"key":"7098_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C, Malik C, Hradsky A, Adu D, Bavanandan S, Cusumano A, Sola L, Ulasi I, Jha V, American Society of Nephrology, European Renal Association, International Society of Nephrology (2024) Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 20:473\u2013485","journal-title":"Nat Rev Nephrol"},{"key":"7098_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/978-3-662-43596-0_19","volume-title":"Pediatric Nephrology","author":"G van der Watt","year":"2016","unstructured":"van der Watt G, Omar F, Brink A, McCulloch M (2016) Laboratory investigation of the child with suspected renal disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 613\u2013636","edition":"7"},{"key":"7098_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-013-2435-6","volume":"28","author":"D Bockenhauer","year":"2013","unstructured":"Bockenhauer D (2013) Over- or underfill: not all nephrotic states are created equal. Pediatr Nephrol 28:1153\u20131156","journal-title":"Pediatr Nephrol"},{"key":"7098_CR27","first-page":"33","volume":"108","author":"R Khanna","year":"2011","unstructured":"Khanna R (2011) Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome. Mo Med 108:33\u201336","journal-title":"Mo Med"},{"key":"7098_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mej\u00eda-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J (2021) Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100:753\u2013779","journal-title":"Kidney Int"},{"key":"7098_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195968","volume":"11","author":"F Marques","year":"2022","unstructured":"Marques F, Reis J, Godinho I, Pereira M, Fernandes P, Jorge S, Lopes JA, Gameiro J (2022) Impact of early proteinuria reduction in glomerular disease and decline of kidney function: a retrospective cohort. J Clin Med 11:5968","journal-title":"J Clin Med"},{"key":"7098_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.23876\/j.krcp.23.127","volume":"43","author":"M Honda","year":"2024","unstructured":"Honda M, Yanagihara T, Gotoh Y (2024) School urinary screening program in Japan: history, outcomes, perspectives. Kidney Res Clin Pract 43:287\u2013298","journal-title":"Kidney Res Clin Pract"},{"key":"7098_CR31","first-page":"623","volume":"66","author":"T Matusmura","year":"2013","unstructured":"Matusmura T, Kurayama H, Kanamoto K, Anzai M (2013) School urinary screening in Chiba city. Jpn J Pediatr 66:623\u2013629","journal-title":"Jpn J Pediatr"},{"key":"7098_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1681\/ASN.V101101","volume":"10","author":"N Yoshikawa","year":"1999","unstructured":"Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M, The Japanese Pediatric IgA Nephropathy Treatment Study Group (1999) A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10:101\u2013109","journal-title":"J Am Soc Nephrol"},{"key":"7098_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2000.8966","volume":"36","author":"G D'Amico","year":"2000","unstructured":"D\u2019Amico G (2000) Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 36:227\u2013237","journal-title":"Am J Kidney Dis"},{"key":"7098_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2215\/CJN.01120905","volume":"1","author":"N Yoshikawa","year":"2006","unstructured":"Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group (2006) Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol 1:511\u2013517","journal-title":"Clin J Am Soc Nephrol"},{"key":"7098_CR35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00467-007-0731-8","volume":"23","author":"N Yoshikawa","year":"2008","unstructured":"Yoshikawa N, Nakanishi K, Ishikura K, Hataya H, Iijima K, Honda M, Japanese Pediatric IgA Nephropathy Treatment Study Group (2008) Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study. Pediatr Nephrol 23:757\u2013763","journal-title":"Pediatr Nephrol"},{"key":"7098_CR36","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00467-018-4011-6","volume":"33","author":"Y Shima","year":"2018","unstructured":"Shima Y, Nakanishi K, Kaku Y, Ishikura K, Hataya H, Matsuyama T, Honda M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group (2018) Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT. Pediatr Nephrol 33:2103\u20132112","journal-title":"Pediatr Nephrol"},{"key":"7098_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00467-008-1006-8","volume":"24","author":"K Nakanishi","year":"2009","unstructured":"Nakanishi K, Iijima K, Ishikura K, Hataya H, Awazu M, Sako M, Honda M, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group (2009) Efficacy and safety of lisinopril for mild childhood IgA nephropathy: a pilot study. Pediatr Nephrol 24:845\u2013849","journal-title":"Pediatr Nephrol"},{"key":"7098_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00467-018-4099-8","volume":"34","author":"Y Shima","year":"2019","unstructured":"Shima Y, Nakanishi K, Sako M, Saito-Oba M, Hamasaki Y, Hataya H, Honda M, Kamei K, Ishikura K, Ito S, Kaito H, Tanaka R, Nozu K, Nakamura H, Ohashi Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC) (2019) Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study). Pediatr Nephrol 34:837\u2013846","journal-title":"Pediatr Nephrol"},{"key":"7098_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00467-007-0726-5","volume":"23","author":"N Yata","year":"2008","unstructured":"Yata N, Nakanishi K, Shima Y, Togawa H, Obana M, Sako M, Nozu K, Tanaka R, Iijima K, Yoshikawa N (2008) Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 23:905\u2013912","journal-title":"Pediatr Nephrol"},{"key":"7098_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.ajkd.2003.11.005","volume":"43","author":"K Yamagata","year":"2004","unstructured":"Yamagata K, Takahashi H, Suzuki S, Mase K, Hagiwara M, Shimizu Y, Hirayama K, Kobayashi M, Narita M, Koyama A (2004) Age distribution and yearly changes in the incidence of ESRD in Japan. Am J Kidney Dis 43:433\u2013443","journal-title":"Am J Kidney Dis"},{"key":"7098_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","volume":"27","author":"J Harambat","year":"2012","unstructured":"Harambat J, van Stralen KJ, Kim JJ, Tizard EJ (2012) Epidemiology of chronic kidney disease in children. Pediatr Nephrol 27:363\u2013373","journal-title":"Pediatr Nephrol"},{"key":"7098_CR42","first-page":"134","volume":"42","author":"CY Lin","year":"2001","unstructured":"Lin CY, Sheng CC, Lin CC, Chen CH, Chou P (2001) Mass urinary screening and follow-up for school children in Taiwan Province. Acta Paediatr Taiwan 42:134\u2013140","journal-title":"Acta Paediatr Taiwan"},{"key":"7098_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00467-005-1915-8","volume":"20","author":"YH Park","year":"2005","unstructured":"Park YH, Choi JY, Chung HS, Koo JW, Kim SY, Namgoong MK, Park YS, Yoo KH, Lee KY, Lee DY, Lee SJ, Lee JE, Chung WY, Hah TS, Cheong HI, Choi Y, Lee KS (2005) Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol 20:1126\u20131130","journal-title":"Pediatr Nephrol"},{"key":"7098_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s004679900278","volume":"14","author":"C Lin","year":"2000","unstructured":"Lin C, Sheng C, Chen C, Lin C, Chou P (2000) The prevalence of heavy proteinuria and progression risk factors in children undergoing urinary screening. Pediatr Nephrol 14:953\u2013959","journal-title":"Pediatr Nephrol"},{"key":"7098_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3904\/kjim.2011.26.2.123","volume":"26","author":"DC Jin","year":"2011","unstructured":"Jin DC (2011) Current status of dialysis therapy in Korea. Korean J Intern Med 26:123\u2013131","journal-title":"Korean J Intern Med"},{"key":"7098_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000495751","volume":"5","author":"R Coppo","year":"2019","unstructured":"Coppo R (2019) Pediatric IgA nephropathy in Europe. Kidney Dis (Basel) 5:182\u2013188","journal-title":"Kidney Dis (Basel)"},{"key":"7098_CR47","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1542\/peds.2007-2901","volume":"120","author":"Committee on Practice and Ambulatory Medicine","year":"2007","unstructured":"Committee on Practice and Ambulatory Medicine, Bright Futures Steering Committee (2007) Recommendations for preventive pediatric health care. Pediatrics 120:1376","journal-title":"Pediatrics"},{"key":"7098_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0022-3476(76)81012-8","volume":"88","author":"WF Dodge","year":"1976","unstructured":"Dodge WF, West EF, Smith EH, Harvey B 3rd (1976) Proteinuria and hematuria in schoolchildren: epidemiology and early natural history. J Pediatr 88:327\u2013347","journal-title":"J Pediatr"},{"key":"7098_CR49","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1542\/peds.100.6.919","volume":"100","author":"RE Kaplan","year":"1997","unstructured":"Kaplan RE, Springate JE, Feld LG (1997) Screening dipstick urinalysis: a time to change. Pediatrics 100:919\u2013921","journal-title":"Pediatrics"},{"key":"7098_CR50","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1542\/peds.2009-1980","volume":"125","author":"DL Sekhar","year":"2010","unstructured":"Sekhar DL, Wang L, Hollenbeak CS, Widome MD, Paul IM (2010) A cost-effectiveness analysis of screening urine dipsticks in well-child care. Pediatrics 125:660\u2013663","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"7098_CR51","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1681\/ASN.V13suppl_1s37","volume":"13","author":"MJ Lysaght","year":"2002","unstructured":"Lysaght MJ (2002) Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13(Suppl 1):S37\u2013S40","journal-title":"J Am Soc Nephrol"},{"key":"7098_CR52","doi-asserted-by":"publisher","first-page":"e.2356412","DOI":"10.1001\/jamanetworkopen.2023.56412","volume":"7","author":"K Honda","year":"2024","unstructured":"Honda K, Akune Y, Goto R (2024) Cost-effectiveness of school urinary screening for early detection of IgA nephropathy in Japan. JAMA Netw Open 7:e.2356412","journal-title":"JAMA Netw Open"},{"key":"7098_CR53","doi-asserted-by":"publisher","first-page":"e1378","DOI":"10.1016\/S2214-109X(25)00198-6","volume":"13","author":"GBD 2023 Kidney Failure with Replacement Therapy Collaborators","year":"2025","unstructured":"GBD 2023 Kidney Failure with Replacement Therapy Collaborators (2025) Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Glob Health 13:e1378\u2013e1395","journal-title":"Lancet Glob Health"},{"key":"7098_CR54","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00467-016-3512-4","volume":"32","author":"AG Abraham","year":"2017","unstructured":"Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, Mu\u00f1oz A (2017) Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol 32:643\u2013649","journal-title":"Pediatr Nephrol"},{"key":"7098_CR55","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1681\/ASN.2018010036","volume":"29","author":"SM van den Belt","year":"2018","unstructured":"van den Belt SM, Heerspink HJL, Gracchi V, de Zeeuw D, W\u00fchl E, Schaefer F, ESCAPE Trial Group (2018) Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD. J Am Soc Nephrol 29:2225\u20132233","journal-title":"J Am Soc Nephrol"},{"key":"7098_CR56","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1053\/j.ajkd.2015.01.008","volume":"65","author":"BA Warady","year":"2015","unstructured":"Warady BA, Abraham AG, Schwartz GJ, Wong CS, Mu\u00f1oz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S (2015) Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis 65:878\u2013888","journal-title":"Am J Kidney Dis"},{"key":"7098_CR57","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/978-3-662-43596-0_22","volume-title":"Pediatric Nephrology","author":"AB Fogo","year":"2016","unstructured":"Fogo AB (2016) Pediatric renal pathology. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 705\u2013749","edition":"7"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07098-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07098-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:03:35Z","timestamp":1783328615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07098-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7098"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07098-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.Consent to participate","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}